Your browser doesn't support javascript.
loading
Clinical characterization and treatment outcomes of follicular cutaneous immune-related adverse events caused by immune checkpoint inhibitors: A multicenter retrospective study.
Freites-Martinez, Azael; Nikolaou, Vasiliki; Lallas, Konstantinos; Carrera, Cristina; Sollena, Pietro; Apalla, Zoe; Starace, Michela; Fattore, Davide; Fabbrocini, Gabriella; Segura, Sonia; Riganti, Julia; Sibaud, Vincent.
Afiliação
  • Freites-Martinez A; Oncodermatology Clinic, Hospital Ruber Juan Bravo and Universidad Europea, Madrid, Spain. Electronic address: azaelfreites@yahoo.com.
  • Nikolaou V; First Department of Dermatology, "Andreas Sygros" Hospital for Skin Diseases, National and Kapodestrian University of Athens, Medical School, Athens, Greece.
  • Lallas K; First Department of Dermatology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Carrera C; Dermatology Department, Hospital Clinic of Barcelona, University of Barcelona, Melanoma Group, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain; Biomedical Research Networking Center on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain.
  • Sollena P; Dermatology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Apalla Z; Second Dermatology Department, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Starace M; Department of Specialized, Dermatology-IRCCS, Policlinico Sant'Orsola, Experimental and Diagnostic Medicine, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
  • Fattore D; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
  • Fabbrocini G; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
  • Segura S; Department of Dermatology, Hospital del Mar - Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Riganti J; Dermatology Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Sibaud V; Oncodermatology Department, Institut Universitaire du cancer, Toulouse Oncopole, Toulouse, France.
J Am Acad Dermatol ; 88(3): 718-720, 2023 Mar.
Article em En | MEDLINE | ID: mdl-36152697
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Clinical_trials / Observational_studies Limite: Humans Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Clinical_trials / Observational_studies Limite: Humans Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2023 Tipo de documento: Article